25545-03-3
beta-D-Arabinofuranose (9CI)
CAS: 25545-03-3
Molecular Formula: C5H10O5
25545-03-3 - Names and Identifiers
25545-03-3 - Physico-chemical Properties
| Molecular Formula | C5H10O5 |
| Molar Mass | 150.13 |
| Density | 1.681±0.06 g/cm3(Predicted) |
| Boling Point | 375.4±42.0 °C(Predicted) |
| pKa | 12.16±0.70(Predicted) |
25545-03-3 - Upstream Downstream Industry
| Downstream Products | THYMINE-BETA-D-ARABINOFURANOSIDE |
25545-03-3 - Introduction
beta-D-Arabinofuranose (9CI) (beta-D-Arabinofuranose) is an organic compound with a chemical formula of C5H10O5 and a molecular weight of 150.13g/mol. It is an impurity of Fludarabine and is commonly used in pharmaceutical research and preparation.
The use of beta-D-Arabinofuranose (9CI) is mainly as a fludarabine drug research and analysis, including drug quality control, purification and stability research. It is one of the structural features of fludarabine and has an impact on the activity and pharmacokinetic properties of the drug.
Regarding the production process, the production of beta-D-Arabinofuranose (9CI) is usually carried out by a synthetic chemical method. Specific methods of preparation may involve chemical reactions on appropriate precursor compounds or synthesis by synthetic routes.
In terms of safety information, beta-D-Arabinofuranose (9CI) specific toxicological data and safety information may require further research and evaluation. When operating in the laboratory, it is necessary to take appropriate safety measures, including wearing personal protective equipment, following correct laboratory procedures, and strictly following relevant chemical safety management regulations.
In view of the fact that beta-D-Arabinofuranose (9CI) is a drug impurity, it is recommended that during use and handling, strictly comply with relevant regulations and legal requirements, and handle and dispose of it in accordance with relevant standards.
The use of beta-D-Arabinofuranose (9CI) is mainly as a fludarabine drug research and analysis, including drug quality control, purification and stability research. It is one of the structural features of fludarabine and has an impact on the activity and pharmacokinetic properties of the drug.
Regarding the production process, the production of beta-D-Arabinofuranose (9CI) is usually carried out by a synthetic chemical method. Specific methods of preparation may involve chemical reactions on appropriate precursor compounds or synthesis by synthetic routes.
In terms of safety information, beta-D-Arabinofuranose (9CI) specific toxicological data and safety information may require further research and evaluation. When operating in the laboratory, it is necessary to take appropriate safety measures, including wearing personal protective equipment, following correct laboratory procedures, and strictly following relevant chemical safety management regulations.
In view of the fact that beta-D-Arabinofuranose (9CI) is a drug impurity, it is recommended that during use and handling, strictly comply with relevant regulations and legal requirements, and handle and dispose of it in accordance with relevant standards.
Last Update：2024-04-09 21:49:45
Supplier List
Spot supply
Product Name: Fludarabine Phosphate Impurity 21 Visit Supplier Webpage Request for quotationCAS: 25545-03-3
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Spot supply
Product Name: Fludarabine Phosphate Impurity 21 Visit Supplier Webpage Request for quotationCAS: 25545-03-3
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History
Downstream Products for 25545-03-3